Immunoprecipitation Market Share, Growth, Opportunities 2031
Immunoprecipitation Market Share, Growth, Opportunities 2031
Segments - Immunoprecipitation Market by Types (Tagged Proteins, Ribonucleoprotein, Chromatin, Protein Complex, and Individual Protein), Products (Reagents [Beads, Antibodies, and Others] and Kits), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-4126
| 4.4 Rating
| 73 Reviews
| 189 Pages
| Format :
Report Description
The Global Immunoprecipitation Market size was valued at USD 729.46 Million in 2022 and is expected to surpass USD 1.61 Billion by 2031, expanding at a CAGR of 9.2% during the forecast period, 2023 – 2031. The growth of the market is attributed to increase in research activity in the life sciences sector.
Immunoprecipitation is one of the most extensively utilized techniques in present cell biology for probing protein–protein interactions. Collaborative efforts between organizations and researchers have aided the expansion of the life science industry significantly. Academic advances in the study of cellular and genetic therapies have resulted in novel strategies for biological therapeutics.
The scope of new discoveries is expanding as the number of research efforts in microbiome, immunotherapy, and genomics grows. With the emergence of advanced genetic tools, R&D for genomics for clinical research, medication discovery, and customized therapy design has grown steadily. Many regulatory and federal agencies are launching strategic measures to support genetic research and improve their region's healthcare system.
The cost of genomic-based research is high, necessitating increased funding. In immunoprecipitation techniques, technological developments are clearly visible. Chromatrap Immunoprecipitation (ChIP) technology developed as a result of advancements in the chromatin immunoprecipitation methodology. A bead-free approach of chromatin immunoprecipitation has been developed due to advancements in the technique, which is termed as Chromatrap Immunoprecipitation (ChIP).
Market Trends, Drivers, Restraints, and Opportunities
-
Increasing technological advancements in immunoprecipitation method is estimated to drive the market.
-
Academic developments in the fields of cellular and genetic therapies have resulted in innovative approaches for biological therapeutics, which is projected to fuel the market.
-
Increasing number of cancer cases and the demand for precision medications is expected to boost the immunoprecipitation market during the forecast period.
-
Rising cardiovascular and orthopedic disorders, as well as the demand for precision drugs to treat them is anticipated to propel the market.
-
Growing importance of stem cell therapy in the development of cell-based treatments is one of the major factors driving the market.
-
Availability of alternate protein isolation technologies is estimated to hamper the market growth.
-
R&D investment and technological advancement in the immunoprecipitation is projected to create lucrative opportunities for the market players.
Scope of Immunoprecipitation Market Report
The report on the global immunoprecipitation market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Immunoprecipitation Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023 – 2031 |
|
Segmentation |
Types (Tagged Proteins, Ribonucleoprotein, Chromatin, Protein Complex, and Individual Protein), Products (Reagents [Beads, Antibodies, and Others] and Kits), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Geno Technology Inc.; Cell Signaling Technology, Inc.; Abbkine Scientific Co., Ltd.; Rockland Immunochemicals Inc.; BioLegend; Takara Bio Inc.; Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific |
Immunoprecipitation Market Segment Insights
The individual protein segment accounted for a major market share in 2021
Based on types, the market is segregated into tagged proteins, ribonucleoprotein, chromatin, protein complex, and individual protein. The individual protein segment accounted for a major market share in 2021. The most typical application of immunoprecipitation, in which a specific protein is extracted, is for protein purification.
The co-immunoprecipitation, on the other hand, is linked to protein-protein interactions, in which an unknown protein is isolated from a complex solution of a known protein. The tagged proteins segment is anticipated to expand at a rapid pace during the forecast period. Due to the limitations on standard immunoprecipitation techniques, tagged protein segment has become popular. Immunoprecipitation of several proteins is impossible due to a shortage of antibodies.
The reagents segment held major market share in 2021
On the basis of products, the market is bifurcated into reagents and kits. The reagents segment is further divided into beads, antibodies, and others. The reagents segment held major market share in 2021 owing to frequent use of several buffers, beads, and antibodies. Researchers frequently utilize agarose beads to purify proteins.
However, since the introduction of magnetic beads, demand for them has increased, propelling the immunoprecipitation market. The kits segment is estimated to expand at a significant rate during the forecast period owing to availability of extensive product range. They include, SureBeads Starter kit, Methylated DNA Immunoprecipitation (MeDIP) kit, and Imprint Chromatin Immunoprecipitation kit.
The academic & research institutes segment dominated the market in 2021
In terms of end-users, the market is fragmented as contract research organizations, pharmaceutical & biotechnology companies, and academic & research institutes. The academic & research institutes segment dominates the market. Growth of the segment is attributed to increasing government funding for R&D activities.
Furthermore, the expansion of this segment is aided by increased collaborative efforts between organizations and academia. The contract research organizations segment is expected to expand at a high CAGR during the forecast period. Major companies are constantly outsourcing their drug development activities and research to CROs in order to increase profit margins. This is projected to drive the market during the projected period.
Asia Pacific is projected to register a substantial growth during the forecast period
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is projected to register a substantial growth during the projected period. Growth of the market in the region is attributed to rising disposable income and infrastructure development in developing countries such as India and China.
North America accounted for a major market share in 2021 owing increasing R&D spending by biotechnology and pharmaceutical companies. Furthermore, rising life science sector in the United States is enabling extensive use of immunoprecipitation techniques, hence improving protein purification procedures. Another aspect propelling the market is technological improvements in this region.
Segments
The global immunoprecipitation market has been segmented on the basis of
Types
- Tagged Proteins
- Ribonucleoprotein
- Chromatin
- Protein Complex
- Individual Protein
Products
- Reagents
- Beads
- Antibodies
- Others
- Kits
End-users
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Geno Technology Inc.
- Cell Signaling Technology, Inc.
- Abbkine Scientific Co., Ltd.
- Rockland Immunochemicals Inc.
- BioLegend
- Takara Bio Inc.
- Bio-Rad Laboratories
- Merck KGaA
- GenScript Biotech Corporation
- Abcam plc
- Thermo Fisher Scientific
Competitive Landscape
Key players competing in the immunoprecipitation market include Geno Technology Inc.; Cell Signaling Technology, Inc.; Abbkine Scientific Co., Ltd.; Rockland Immunochemicals Inc.; BioLegend; Takara Bio Inc.; Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific.
Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
-
In 2018, Abbkine introduced Conjugated Tag Antibodies with Agarose/Magnetic Beads, allowing for a quick and easy tagged protein immunoprecipitation.
-
In April 2019, REMD Biotherapeutics Inc and GenScript Biotech Corporation have formed a strategic partnership to develop new immunotherapy medications based on bispecific antibodies.
Frequently Asked Questions
The immunoprecipitation market is projected to expand at a CAGR of around 9.2% during the forecast period, 2022 – 2030.
The immunoprecipitation market size was valued at USD 668 million in 2021.
The academic & research institutes segment dominated the market in 2021
Availability of alternate protein isolation technologies is estimated to hinder the market growth.
Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific are some of the top players in the market.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoprecipitation Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunoprecipitation Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunoprecipitation Market - Supply Chain
4.5. Global Immunoprecipitation Market Forecast
4.5.1. Immunoprecipitation Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunoprecipitation Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Immunoprecipitation Market Absolute $ Opportunity
5. Global Immunoprecipitation Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Immunoprecipitation Market Size and Volume Forecast by Types
5.3.1. Tagged Proteins
5.3.2. Ribonucleoprotein
5.3.3. Chromatin
5.3.4. Protein Complex
5.3.5. Individual Protein
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Immunoprecipitation Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Immunoprecipitation Market Size and Volume Forecast by End Users
6.3.1. Contract Research Organizations
6.3.2. Pharmaceutical & Biotechnology Companies
6.3.3. Academic & Research Institutes
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Immunoprecipitation Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Immunoprecipitation Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Immunoprecipitation Demand Share Forecast, 2019-2026
8. North America Immunoprecipitation Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Immunoprecipitation Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Immunoprecipitation Market Size and Volume Forecast by Types
8.4.1. Tagged Proteins
8.4.2. Ribonucleoprotein
8.4.3. Chromatin
8.4.4. Protein Complex
8.4.5. Individual Protein
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Immunoprecipitation Market Size and Volume Forecast by End Users
8.7.1. Contract Research Organizations
8.7.2. Pharmaceutical & Biotechnology Companies
8.7.3. Academic & Research Institutes
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Immunoprecipitation Demand Share Forecast, 2019-2026
9. Latin America Immunoprecipitation Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Immunoprecipitation Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Immunoprecipitation Market Size and Volume Forecast by Types
9.4.1. Tagged Proteins
9.4.2. Ribonucleoprotein
9.4.3. Chromatin
9.4.4. Protein Complex
9.4.5. Individual Protein
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Immunoprecipitation Market Size and Volume Forecast by End Users
9.7.1. Contract Research Organizations
9.7.2. Pharmaceutical & Biotechnology Companies
9.7.3. Academic & Research Institutes
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Immunoprecipitation Demand Share Forecast, 2019-2026
10. Europe Immunoprecipitation Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Immunoprecipitation Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Immunoprecipitation Market Size and Volume Forecast by Types
10.4.1. Tagged Proteins
10.4.2. Ribonucleoprotein
10.4.3. Chromatin
10.4.4. Protein Complex
10.4.5. Individual Protein
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Immunoprecipitation Market Size and Volume Forecast by End Users
10.7.1. Contract Research Organizations
10.7.2. Pharmaceutical & Biotechnology Companies
10.7.3. Academic & Research Institutes
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Immunoprecipitation Demand Share Forecast, 2019-2026
11. Asia Pacific Immunoprecipitation Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Types
11.4.1. Tagged Proteins
11.4.2. Ribonucleoprotein
11.4.3. Chromatin
11.4.4. Protein Complex
11.4.5. Individual Protein
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by End Users
11.7.1. Contract Research Organizations
11.7.2. Pharmaceutical & Biotechnology Companies
11.7.3. Academic & Research Institutes
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Immunoprecipitation Demand Share Forecast, 2019-2026
12. Middle East & Africa Immunoprecipitation Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Types
12.4.1. Tagged Proteins
12.4.2. Ribonucleoprotein
12.4.3. Chromatin
12.4.4. Protein Complex
12.4.5. Individual Protein
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by End Users
12.7.1. Contract Research Organizations
12.7.2. Pharmaceutical & Biotechnology Companies
12.7.3. Academic & Research Institutes
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Immunoprecipitation Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Immunoprecipitation Market: Market Share Analysis
13.2. Immunoprecipitation Distributors and Customers
13.3. Immunoprecipitation Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Geno Technology Inc.
13.4.2. Cell Signaling Technology, Inc.
13.4.3. Abbkine Scientific Co., Ltd.
13.4.4. Rockland Immunochemicals Inc.
13.4.5. BioLegend
13.4.6. Takara Bio Inc.
13.4.7. Bio-Rad Laboratories
13.4.8. Merck
Methodology
Related Reports
Some other reports from this category!
Our Clients
